-
1
-
-
36649035320
-
Renal transplantation from extended criteria cadaveric donors: Problems and perspectives overview
-
DOI 10.1111/j.1432-2277.2007.00543.x
-
Audard V, Matignon M, Dahan K, Lang P, Grimbert P,. Renal transplantation from extended criteria cadaveric donors: Problems and perspectives overview. Transpl Int 2008; 21: 11-17. (Pubitemid 350198281)
-
(2008)
Transplant International
, vol.21
, Issue.1
, pp. 11-17
-
-
Audard, V.1
Matignon, M.2
Dahan, K.3
Lang, P.4
Grimbert, P.5
-
2
-
-
65549142166
-
Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005
-
Collins MG, Chang SH, Russ GR, McDonald SP,. Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005. Transplantation 2009; 87: 1201-1209.
-
(2009)
Transplantation
, vol.87
, pp. 1201-1209
-
-
Collins, M.G.1
Chang, S.H.2
Russ, G.R.3
McDonald, S.P.4
-
3
-
-
16244395140
-
Current status of kidney and pancreas transplantation in the United States, 1994-2003
-
The 2004 SRTR Report on the State of Transplantation
-
Danovitch GM, Cohen DJ, Weir MR, et al,. Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant 2005; 5: 904-915. (Pubitemid 40461263)
-
(2005)
American Journal of Transplantation
, vol.5
, Issue.4
, pp. 904-915
-
-
Danovitch, G.M.1
Cohen, D.J.2
Weir, M.R.3
Stock, P.G.4
Bennett, W.M.5
Christensen, L.L.6
Sung, R.S.7
-
4
-
-
0038751995
-
Expanded criteria donors for kidney transplantation
-
DOI 10.1034/j.1600-6143.3.s4.11.x
-
Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM,. Expanded criteria donors for kidney transplantation. Am J Transplant 2003; 3 (Suppl 4): 114-125. (Pubitemid 36612389)
-
(2003)
American Journal of Transplantation
, vol.3
, Issue.SUPPL. 4
, pp. 114-125
-
-
Metzger, R.A.1
Delmonico, F.L.2
Feng, S.3
Port, F.K.4
Wynn, J.J.5
Merion, R.M.6
-
5
-
-
0035126261
-
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates
-
Ojo AO, Hanson JA, Meier-Kriesche H, et al,. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589-597. (Pubitemid 32180029)
-
(2001)
Journal of the American Society of Nephrology
, vol.12
, Issue.3
, pp. 589-597
-
-
Ojo, A.O.1
Hanson, J.A.2
Meier-Kriesche, H.-U.3
Okechukwu, C.N.4
Wolfe, R.A.5
Leichtman, A.B.6
Agodoa, L.Y.7
Kaplan, B.8
Port, F.K.9
-
6
-
-
0037112888
-
Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors
-
Port FK, Bragg-Gresham JL, Metzger RA, et al,. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281-1286. (Pubitemid 35402598)
-
(2002)
Transplantation
, vol.74
, Issue.9
, pp. 1281-1286
-
-
Port, F.K.1
Bragg-Gresham, J.L.2
Metzger, R.A.3
Dykstra, D.M.4
Gillespie, B.W.5
Young, E.W.6
Delmonico, F.L.7
Wynn, J.J.8
Merion, R.M.9
Wolfe, R.A.10
Held, P.J.11
-
7
-
-
35748945714
-
Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: Realities and costs
-
DOI 10.1111/j.1600-6143.2007.01993.x
-
Saidi RF, Elias N, Kawai T, et al,. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: Realities and costs. Am J Transplant 2007; 7: 2769-2774. (Pubitemid 350045769)
-
(2007)
American Journal of Transplantation
, vol.7
, Issue.12
, pp. 2769-2774
-
-
Saidi, R.F.1
Elias, N.2
Kawai, T.3
Hertl, M.4
Farrell, M.-L.5
Goes, N.6
Wong, W.7
Hartono, C.8
Fishman, J.A.9
Kotton, C.N.10
Tolkoff-Rubin, N.11
Delmonico, F.L.12
Cosimi, A.B.13
Ko, D.S.C.14
-
8
-
-
0021690115
-
Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: Beneficial effect of low doses in early post-transplantation period
-
Klintmalm G, Bohman SO, Sundelin B, Wilczek H,. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: Beneficial effect of low doses in early post-transplantation period. Lancet 1984; 2: 950-954.
-
(1984)
Lancet
, vol.2
, pp. 950-954
-
-
Klintmalm, G.1
Bohman, S.O.2
Sundelin, B.3
Wilczek, H.4
-
10
-
-
0344666767
-
The Natural History of Chronic Allograft Nephropathy
-
DOI 10.1056/NEJMoa020009
-
Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR,. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333. (Pubitemid 37509740)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.24
, pp. 2326-2333
-
-
Nankivell, B.J.1
Borrows, R.J.2
Fung, C.L.-S.3
O'Connell, P.J.4
Allen, R.D.M.5
Chapman, J.R.6
-
11
-
-
77954623148
-
Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure
-
Gaston RS, Cecka JM, Kasiske BL, et al,. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68-74.
-
(2010)
Transplantation
, vol.90
, pp. 68-74
-
-
Gaston, R.S.1
Cecka, J.M.2
Kasiske, B.L.3
-
12
-
-
0036820323
-
Cardiovascular toxicities of immunosuppressive agents
-
DOI 10.1034/j.1600-6143.2002.20902.x
-
Miller LW,. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002; 2: 807-818. (Pubitemid 36306835)
-
(2002)
American Journal of Transplantation
, vol.2
, Issue.9
, pp. 807-818
-
-
Miller, L.W.1
-
13
-
-
10844292763
-
Immunosuppressive drugs for kidney transplantation
-
DOI 10.1056/NEJMra033540
-
Halloran PF,. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715-2729. (Pubitemid 39665325)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.26
, pp. 2715-2729
-
-
Halloran, P.F.1
-
14
-
-
0036314948
-
Post-transplant renal function in the first year predicts long-term kidney transplant survival
-
DOI 10.1046/j.1523-1755.2002.00424.x
-
Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP,. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311-318. (Pubitemid 34754077)
-
(2002)
Kidney International
, vol.62
, Issue.1
, pp. 311-318
-
-
Hariharan, S.1
McBride, M.A.2
Cherikh, W.S.3
Tolleris, C.B.4
Bresnahan, B.A.5
Johnson, C.P.6
-
15
-
-
1442338509
-
Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates over the Most Recent Era
-
DOI 10.1111/j.1600-6143.2004.00332.x
-
Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B,. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383. (Pubitemid 38282293)
-
(2004)
American Journal of Transplantation
, vol.4
, Issue.3
, pp. 378-383
-
-
Meier-Kriesche, H.-U.1
Schold, J.D.2
Srinivas, T.R.3
Kaplan, B.4
-
16
-
-
34547957878
-
Renal transplantation in high-risk patients
-
DOI 10.2165/00003495-200767110-00005
-
Weimert NA, Alloway RR,. Renal transplantation in high-risk patients. Drugs 2007; 67: 1603-1627. (Pubitemid 47267299)
-
(2007)
Drugs
, vol.67
, Issue.11
, pp. 1603-1627
-
-
Weimert, N.A.1
Alloway, R.R.2
-
17
-
-
20044386299
-
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties
-
DOI 10.1111/j.1600-6143.2005.00749.x
-
Larsen CP, Pearson TC, Adams AB, et al,. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 2005; 5: 443-453. (Pubitemid 40313335)
-
(2005)
American Journal of Transplantation
, vol.5
, Issue.3
, pp. 443-453
-
-
Larsen, C.P.1
Pearson, T.C.2
Adams, A.B.3
Tso, P.4
Shirasugi, N.5
Strobert, E.6
Anderson, D.7
Cowan, S.8
Price, K.9
Naemura, J.10
Emswiler, J.11
Greene, J.12
Turk, L.A.13
Bajorath, J.14
Townsend, R.15
Hagerty, D.16
Linsley, P.S.17
Peach, R.J.18
-
18
-
-
76949090842
-
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)
-
Durrbach A, Pestana JM, Pearson T, et al,. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant 2010; 10: 547-557.
-
(2010)
Am J Transplant
, vol.10
, pp. 547-557
-
-
Durrbach, A.1
Pestana, J.M.2
Pearson, T.3
-
19
-
-
78650831358
-
Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies
-
Larsen CP, Grinyo J, Medina-Pestana J, et al,. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation 2010; 90: 1528-1535.
-
(2010)
Transplantation
, vol.90
, pp. 1528-1535
-
-
Larsen, C.P.1
Grinyo, J.2
Medina-Pestana, J.3
-
20
-
-
76949101581
-
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)
-
Vincenti F, Charpentier B, Vanrenterghem Y, et al,. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010; 10: 535-546.
-
(2010)
Am J Transplant
, vol.10
, pp. 535-546
-
-
Vincenti, F.1
Charpentier, B.2
Vanrenterghem, Y.3
-
21
-
-
78650818523
-
An integrated safety profile analysis of belatacept in kidney transplant recipients
-
Grinyo J, Charpentier B, Pestana JM, et al,. An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation 2010; 90: 1521-1527.
-
(2010)
Transplantation
, vol.90
, pp. 1521-1527
-
-
Grinyo, J.1
Charpentier, B.2
Pestana, J.M.3
-
22
-
-
0033574249
-
A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
-
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
-
(1999)
Annals of Internal Medicine
, vol.130
, Issue.6
, pp. 461-470
-
-
Levey, A.S.1
Bosch, J.P.2
Lewis, J.B.3
Greene, T.4
Rogers, N.5
Roth, D.6
-
23
-
-
34147205677
-
Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values
-
DOI 10.1373/clinchem.2006.077180
-
Levey AS, Coresh J, Greene T, et al,. Expressing the modification of diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-772. (Pubitemid 46580250)
-
(2007)
Clinical Chemistry
, vol.53
, Issue.4
, pp. 766-772
-
-
Levey, A.S.1
Coresh, J.2
Greene, T.3
Marsh, J.4
Stevens, L.A.5
Kusek, J.W.6
Van Lente, F.7
-
24
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-266.
-
(2002)
Am J Kidney Dis
, vol.39
, Issue.SUPPL. 1
-
-
-
26
-
-
77956528156
-
Five-year safety and efficacy of belatacept in renal transplantation
-
Vincenti F, Blancho G, Durrbach A, et al,. Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol 2010; 21: 1587-1596.
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 1587-1596
-
-
Vincenti, F.1
Blancho, G.2
Durrbach, A.3
-
27
-
-
84857658225
-
Application of a validated long-term renal transplant graft survival prediction model to expected belatacept phase III trial outcomes
-
Schnitzler MA, Trivedi D, L'Italien GJ,. Application of a validated long-term renal transplant graft survival prediction model to expected belatacept phase III trial outcomes. Transplantation 2010; 90 (Suppl 2S): 341.
-
(2010)
Transplantation
, vol.90
, Issue.SUPPL. 2
, pp. 341
-
-
Schnitzler, M.A.1
Trivedi, D.2
L'Italien, G.J.3
-
28
-
-
84855973130
-
Expected median graft survival prediction for belatacept Phase III trial outcomes in kidney transplantation
-
Schnitzler MA, Kalsekar A, You M, L'Italien G,. Expected median graft survival prediction for belatacept Phase III trial outcomes in kidney transplantation. Am J Transplant 2011; 11 (S2): 353-354.
-
(2011)
Am J Transplant
, vol.11
, Issue.S2
, pp. 353-354
-
-
Schnitzler, M.A.1
Kalsekar, A.2
You, M.3
L'Italien, G.4
-
30
-
-
0346752037
-
Poor Predictive Value of Serum Creatinine for Renal Allograft Loss
-
DOI 10.1046/j.1600-6135.2003.00275.x
-
Kaplan B, Schold J, Meier-Kriesche HU,. Poor predictive value of serum creatinine for renal allograft loss. Am J Transplant 2003; 3: 1560-1565. (Pubitemid 37541513)
-
(2003)
American Journal of Transplantation
, vol.3
, Issue.12
, pp. 1560-1565
-
-
Kaplan, B.1
Schold, J.2
Meier-Kriesche, H.-U.3
-
31
-
-
79951771805
-
On behalf of the patient outcomes in renal transplantation (PORT) investigators. The relationship between kidney function and long-term graft survival after kidney transplant
-
Kasiske BL, Israni AK, Snyder JJ, Skeans MA,. On behalf of the patient outcomes in renal transplantation (PORT) investigators. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis 2011; 57: 466-475.
-
(2011)
Am J Kidney Dis
, vol.57
, pp. 466-475
-
-
Kasiske, B.L.1
Israni, A.K.2
Snyder, J.J.3
Skeans, M.A.4
-
32
-
-
79958717951
-
Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs
-
Schnitzler MA, Johnston K, Axelrod D, Gheorghian A, Lentine KL,. Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation 2011; 91: 1347-1356.
-
(2011)
Transplantation
, vol.91
, pp. 1347-1356
-
-
Schnitzler, M.A.1
Johnston, K.2
Axelrod, D.3
Gheorghian, A.4
Lentine, K.L.5
-
33
-
-
77958086781
-
Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: A cohort study
-
Summers DM, Johnson RJ, Allen J, et al,. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: A cohort study. Lancet 2010; 376: 1303-1311.
-
(2010)
Lancet
, vol.376
, pp. 1303-1311
-
-
Summers, D.M.1
Johnson, R.J.2
Allen, J.3
-
34
-
-
49749140379
-
A systematic review of kidney transplantation from expanded criteria donors
-
Pascual J, Zamora J, Pirsch JD,. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis 2008; 52: 553-586.
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 553-586
-
-
Pascual, J.1
Zamora, J.2
Pirsch, J.D.3
|